Telangana aims to skill 50,000 graduates for life sciences sector, says minister

He said a pilot batch under the government’s skilling initiative with two specialised courses will be started in weeks.

ByPTI

Published Feb 28, 2024 | 3:53 PMUpdatedFeb 28, 2024 | 3:53 PM

Duddilla Sridhar Babu

The Telangana government aims to skill 50,000 local graduates over five to six years to make them industry-ready for life sciences research and manufacturing, Industries Minister D Sridhar Babu said on Wednesday, 28 February.

Speaking at BioAsia, a healthcare and life sciences annual event being held in Hyderabad, he said a pilot batch under the government’s skilling initiative with two specialised courses — medicinal chemistry and analytical chemistry — will be started in weeks.

“Our vision is to expand a strong workforce by skilling nearly 50,000 local graduates over 5-6 years to make them industry-ready for life sciences research and manufacturing. In a weeks’ time, we will start the pilot batch under our skilling initiative with two specialised courses – medicinal chemistry and analytical chemistry,” he said.

Also Read: Rajasthan man held for creating fake social media accounts of Telangana IPS officer

To set up a clinical registry

  • The government has initiated the process of setting up a clinical registry, starting with three pilot sites focusing on the Hemophilia indication, as stated by the minister.
  • Establishing a clinical registry aims to enhance healthcare outcomes and improve the allocation and utilisation of resources, according to the minister.
  • The Centre for the Fourth Industrial Revolution Telangana (C4IR Telangana), inaugurated by the minister, reflects the state government’s strong commitment to advancing society, particularly in healthcare and health technology.
  • C4IR Telangana aims to create over 10,000 new job opportunities in health tech, including R&D and manufacturing roles, nurture 20-25 emerging companies and startups, and generate 10-25 novel ideas through its registry.
  • Telangana is a significant contributor to India’s pharmaceutical production, accounting for 40 percent of the country’s output. It serves as a hub for manufacturing, producing over one-third of the global vaccine supply (approximately 14 billion doses annually) and hosting more than 1,000 global healthcare and life science companies, according to the minister.

(Disclaimer: South First may have reworked the headline, subheads, and format of this report along with the photos. The rest of the content is from a syndicated feed, and has been edited for style.)